Actigraphy-Quantified Physical Activity Measurements in Patients with Symptomatic LMNA-Related Dilated Cardiomyopathy in REALM-Dilated Cardiomyopathy
This is the largest and most longitudinal dataset of <i>LMNA</i>-DCM patients collected and reported to date using wearable sensors to gain understanding of PA patterns in these patients. These data help understand the potential use of actigraphy monitoring and wearable technologies in genetic cardiomyopathy and heart failure clinical trials.
Authors
- Charmaine Demanuele (ORCID: https://orcid.org/0000-0002-7715-9920)
- Junrui Di (ORCID: https://orcid.org/0000-0001-6325-8090)
- Franca S. Angeli
- Pablo García-Pavía
- Calum A. MacRae
- Jonathan Bruno
- Huihua Li
- Tina Marie Hinnershitz
- Xuemei Cai
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Pfizer (United States) (US)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
Publication Details
- Journal
- Digital Biomarkers
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1159/000550259
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer